Advertisement

Journal of General Internal Medicine

, Volume 20, Issue 1, pp 21–27 | Cite as

The association of health-related quality of life with survival among persons with HIV infection in the united states

  • William E. Cunningham
  • Stephen Crystal
  • Samuel Bozzette
  • Ron D. Hays
Original Article

Abstract

OBJECTIVES: Both clinical trials and observational studies of persons with HIV infection commonly include health-related quality of life (HRQOL) measures, but less is known about the relation of HRQOL to survival among persons with HIV since the development of effective antiretroviral treatment.

DESIGN/PARTICIPANTS: Prospective cohort study of a national probability sample of 2,864 adults receiving HIV care.

INDEPENDENT VARIABLES: The main independent variables were derived from the HIV Cost and Services Utilization Study (HCSUS) HRQOL measure, and include physical and mental HRQOL summary scores (divided into quartiles) constructed from the following items administered at baseline: physical functioning (9 items, α=0.91), role functioning (2 items, α=0.85), pain (2 items, α=0.84), general health perceptions (3 items, α=0.80), emotional well-being (7 items, α=0.90), social functioning (2 items, α=0.82), energy (2 items, α=0.74), and a single-item measure of disability days (days in bed for at least 0.5 day due to health).

MAIN OUTCOME VARIABLE: Death between January 1996 and December 1999.

ANALYSIS: Descriptive and multivariate adjusted Cox proportional hazards regression analysis of survival by physical and mental HRQOL.

RESULTS: By December 1999, 17% of the sample had died. In unadjusted analysis, persons in the higher quartiles of physical HRQOL, as well as those in the higher quartiles of mental HRQOL at baseline, had significantly better survival than those in lower quartiles. In multiple regressions controlling for a number of sociodemographic and clinical variables, the hazard of death for those in the highest quartile of physical HRQOL was one quarter of that for those in the lowest quartile. This difference was similar in magnitude to that observed for being on highly active antiretroviral therapy versus no antiretrovirals in this population. By contrast, there was no unique association of mental HRQOL with survival.

CONCLUSIONS: Physical HRQOL added prognostic information over and above the sociodemographic and routinely available clinical data such as CD4 count and stage of HIV infection. Measurement of HRQOL, which is often performed to identify problems or assess outcomes, is also useful prognostically.

Key Words

HIV AIDS quality of life survival outcomes 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Centers for Disease Control and Prevention. HIV/AIDS Surveillance Report, December 2001 Year-end Edition. Atlanta, GA: Centers for Disease Control and Prevention; 2001;13:1–48.Google Scholar
  2. 2.
    Hays RD, Cunningham WE, Sherbourne CD, et al. Health-related quality of life in patients with Human Immunodeficiency Virus Infection in the United States: results from the HIV Cost and Services Utilization Study. Am J Med. 2000;108:714–22.PubMedCrossRefGoogle Scholar
  3. 3.
    Wilson IB, Cleary PD. Linking clinical variables with health-related quality of life: a conceptual model of patient outcomes. JAMA. 1995;273:59–65.PubMedCrossRefGoogle Scholar
  4. 4.
    Ganz PA, Schag CAC, Kahn B, Petersen L. Assessing the quality of life of HIV infected persons: clinical and descriptive information from studies with The Hopes. Psychol Health. 1994;9:93–110.CrossRefGoogle Scholar
  5. 5.
    Globe DR, Hays RD, Cunningham WE. Associations of clinical parameters with health-related quality of life in hospitalized persons with HIV disease. AIDS Care. 1999;11:71–86.PubMedCrossRefGoogle Scholar
  6. 6.
    Wu A, Hays RD, Kelly S, Malitz KF, Bozzette SA. Applications of the medical outcomes study health-related quality of life measures in HIV/AIDS. Qual Life Res. 1997;6:531–54.PubMedCrossRefGoogle Scholar
  7. 7.
    Bozzette SA, Hays RD, Berry SH, Kanouse DE, Wu AW. Derivation and properties of a brief health status assessment instrument for use in HIV disease. J Acquir Immune Defic Syndr Hum Retrovirol. 1995;8:253–65.PubMedGoogle Scholar
  8. 8.
    Chan KS, Revicki DA. Changes in surrogate laboratory markers, clinical endpoints, and health-related quality of life in patients infected with the human immunodeficiency virus. Eval Health Prof. 1998;21:265–81.PubMedCrossRefGoogle Scholar
  9. 9.
    Brechtl JR, Breitbart W, Galietta M, Krivo S, Rosenfeld B. The use of highly active antiretroviral therapy (HAART) in patients with advanced HIV infection: impact on medical, palliative care, and quality of life outcomes. J Pain Symptom Manage. 2001;21:41–51.PubMedCrossRefGoogle Scholar
  10. 10.
    Starace F, Ammassari A, Trotta MP, et al. Depression is a risk factor for suboptimal adherence to highly active antiretroviral therapy. J Acquir Immune Defic Syndr. 2002;31(suppl 3):S136-S139.PubMedGoogle Scholar
  11. 11.
    Palella FJ, Delaney KM, Moorman A, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med. 1998;338:853–60.PubMedCrossRefGoogle Scholar
  12. 12.
    Frankel MR, Shapiro MF, Duan N, et al. National probability samples in studies of low-prevalence diseases, part 2: designing and implementing the HIV cost and services utilization study sample. Health Serv Res. 1999;34:969–92.PubMedGoogle Scholar
  13. 13.
    Hays RD, Spritzer KL, McCaffrey DF, et al. The HIV Cost and Services Utilization Study (HCSUS) Measures of Health-related Quality of Life. Santa Monica, CA: RAND; 1998:DRU-1897-AHCPR.Google Scholar
  14. 14.
    Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents. Department of Health and Human Services and Henry J. Kaiser Family Foundation. MMWR Recomm Rep. 1998;47(RR-5):43–82.Google Scholar
  15. 15.
    Cunningham WE, Markson LE, Andersen RM, et al. Prevalence and predictors of highly active antiretroviral therapy use in persons with HIV infection in the U.S. J Acquir Immune Defic Syndr. 2000;25:115–23.PubMedCrossRefGoogle Scholar
  16. 16.
    Stata Corporation. Stata Reference Manual, V7.0. College Station, TX: Stata Corporation; 2000.Google Scholar
  17. 17.
    Bozzette SA, Berry SH, Duan N, et al. The care of HIV-infected adults in the United States. HIV Cost and Services Utilization Study Consortium. N Engl J Med. 1998;339:1897–904.PubMedCrossRefGoogle Scholar
  18. 18.
    Fleishman JA, Crystal S. Functional status transition and survival in HIV disease: evidence from the AIDS Costs and Service Utilization Survey. Med Care. 1998;36:533–43.PubMedCrossRefGoogle Scholar
  19. 19.
    Jacobson DL, Wu AW, Feinberg J. Outcomes Committee of the Adult AIDS Clinical Trials Group. Health-related quality of life predicts survival, cytomegalovirus disease, and study retention in clinical trial participants with advanced HIV disease. J Clin Epidemiol. 2003;56:874–9.PubMedCrossRefGoogle Scholar
  20. 20.
    Inouye SK, Peduzzi PN, Robison JT, Hughes JS, Horwitz RI, Concato J. Importance of functional measures in predicting mortality among older hospitalized patients. JAMA. 1998;279:1187–93.PubMedCrossRefGoogle Scholar
  21. 21.
    Rumsfeld JS, MaWhinney S, McCarthy M, et al. Health-related quality of life as a predictor of mortality following coronary artery bypass graft surgery. Participants of the Department of Veterans Affairs Cooperative Study Group on Processes, Structures, and Outcomes of Care in Cardiac Surgery. JAMA. 1999;281:1298–303.PubMedCrossRefGoogle Scholar
  22. 22.
    Lee Y. The predictive value of self assessed general, physical, and mental health on functional decline and mortality in older adults. J Epidemiol Community Health. 2000;54:123–9.PubMedCrossRefGoogle Scholar
  23. 23.
    Idler EL, Kasl S. Health perceptions and survival: do global evaluations of health status really predict mortality? J Gerontol. 1991;46:S55-S65.PubMedGoogle Scholar
  24. 24.
    Ware J, Kosinski M, Keller SD. SF-36 Physical and Mental Health Summary Scales: A User’s Manual. Boston, MA: The Health Institute, New England Medical Center; 1994.Google Scholar
  25. 25.
    Konstam V, Salem D, Pouleur H, et al. Baseline quality of life as a predictor of mortality and hospitalization in 5,025 patients with congestive heart failure. SOLVD Investigations. Studies of Left Ventricular Dysfunction Investigators. Am J Cardiol. 1996;78:890–5.PubMedCrossRefGoogle Scholar
  26. 26.
    Reuben DB, Rubenstein LV, Hirsch SH, Hays RD. Value of functional status as a predictor of mortality: results of a prospective study. Am J Med. 1992;93:663–9.PubMedCrossRefGoogle Scholar
  27. 27.
    Idler EL, Benyamini Y. Self-rated health and mortality: a review of twenty-seven community studies. J Health Soc Behav. 1997;38:21–37.PubMedCrossRefGoogle Scholar
  28. 28.
    Douaihy A, Singh N. Factors affecting quality of life in patients with HIV infection. AIDS Read. 2001;11:450–4; 460–1, 475.PubMedGoogle Scholar
  29. 29.
    O’Leary JF, Ganz PA, Wu AW, Coscarelli A, Petersen L. Toward a better understanding of health-related quality of life: a comparison of the Medical Outcomes Study HIV Health Survey (MOS-HIV) and the HIV Overview of Problems-Evaluation System (HOPES). J Acquir Immune Defic Syndr Hum Retrovirol. 1998;17:433–41.PubMedGoogle Scholar
  30. 30.
    Wilson IB, Cleary PD. Clinical predictors of declines in physical functioning in persons with AIDS: results of a longitudinal study. J Acquir Immune Defic Syndr Hum Retrovirol. 1997;16:343–9.PubMedGoogle Scholar
  31. 31.
    Cunningham WE, Hays RD, Ettl MK, et al. The prospective effect of access to medical care on health-related quality-of-life outcomes in patients with symptomatic HIV disease. Med Care. 1998;36:295–306.PubMedCrossRefGoogle Scholar
  32. 32.
    Reemtsma K, Morgan M. Outcomes assessment: a primer. Bull Am Coll Surg. 1997;82:34–9.PubMedGoogle Scholar
  33. 33.
    Detmar SB, Muller MJ, Schornagel JH, Wever LD, Aaronson NK. Health-related quality-of-life assessments and patient-physician communication: a randomized controlled trial. JAMA. 2002;288:3027–34.PubMedCrossRefGoogle Scholar
  34. 34.
    Kiebzak GM, Campbell M, Mauerhan DR. The SF-36 general health status survey documents the burden of osteoarthritis and the benefits of total joint arthroplasty: but why should we use it? Am J Manag Care. 2002;8:463–74.PubMedGoogle Scholar
  35. 35.
    Gilbody SM, House AO, Sheldon T. Routine administration of Health Related Quality of Life (HRQoL) and needs assessment instruments to improve psychological outcome—a systematic review. Psychol Med. 2002;32:1345–56.PubMedCrossRefGoogle Scholar
  36. 36.
    Hays RD, Stewart AL. The structure of self-reported health in chronic disease patients. Psychol Assess. 1990;2:22–30.CrossRefGoogle Scholar
  37. 37.
    Hays RD, Prince-Embury S, Chen H. R-36 HSI: RAND-36 Health Status Inventory. San Antonio, TX: The Psychological Corporation; 1998.Google Scholar
  38. 38.
    Ware JE Jr, Kosinski M, Bayliss MS, McHorney CA, Rogers WH, Raczek A. Comparison of methods for the scoring and statistical analysis of SF-36 health profile and summary measures: summary of results from the Medical Outcomes Study. Med Care. 1995;33:AS264-AS279.PubMedCrossRefGoogle Scholar
  39. 39.
    de Boer AG, Wijker W, Speelman JD, de Haes JC. Quality of life in patients with Parkinson’s disease: development of a questionnaire. J Neurol Neurosurg Psychiatry. 1996;61:70–4.PubMedCrossRefGoogle Scholar

Copyright information

© Society of General Internal Medicine 2005

Authors and Affiliations

  • William E. Cunningham
    • 1
    • 2
  • Stephen Crystal
    • 3
  • Samuel Bozzette
    • 4
    • 5
  • Ron D. Hays
    • 1
    • 2
    • 4
  1. 1.Department of MedicineDivision of General Internal Medicine and Health Services ResearchUSA
  2. 2.Department of Health ServicesUCLA School of Public HealthLos Angeles
  3. 3.Rutgers UniversityNew BrunswickUSA
  4. 4.Health Sciences ProgramRANDSanta MonicaUSA
  5. 5.Veterans Affairs Medical CenterSan DiegoUSA

Personalised recommendations